In particular, we found that CD147 was significantly increased in cancer samples than normal controls in almost all cancers except KIRC, LAML, READ, UCS, SARC, and pheochromocytoma and paraganglioma (PCPG) (Figure 2D; P<0.01). This evidence concerns the gene BSG and cancer.